IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

BASF Plans to Ramp Up R&D Spending

8:55 AM MST | November 7, 2007 | Alex Scott in Berlin

BASF plans to “ramp up” spending to develop diagnostic and prognostic test products designed by its Metanomics Health (Berlin) human health biotechnology business, said Peter Oakley, BASF board member/agricultural products and fine chemicals, at a briefing in Berlin last month. Metanomics Health is developing novel diagnostic tests including products to predict the onset of certain diseases such as diabetes, potentially enabling physicians to prevent their onset. BASF says it has established proof of concept for the tests. Metanomics Health, to...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa